Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2025

Month: February

Request Number: A-2024-000610

Request Summary: Adverse Drug Reactions (ADRs) for C1 Esterase Inhibitor (Human). Report numbers: E2B_07240241, E2B_07202397, E2B_07203738, E2B_07211715, E2B_07200893, E2B_07212141, 001091444. ADR for Mesalimine. Report number: 001097077. ADR for VYVANSE. Report number: 001092714. ADR for MEZAVANT. Report number: 001099893.

Disposition: Disclosed in part

Number of pages: 234

Date modified: